Stuart Gordon, MD
Gastroenterology · Detroit, MINPI 1679641112
Payments from drug & device makers
Across 554 payments — averaging $7740.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1.7M
- Gilead$1.5M
- AbbVie$443K
- Intercept Pharmaceuticals, Inc.$381K
- Takeda Pharmaceuticals U.S.A., Inc.$32K
- Intercept Pharma Europe Ltd.$26K
- plus $112K from 16 others
Across 44 payments — averaging $167.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$4K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Eli Lilly$1K
- GSK$77
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 166 | $1,749,801 |
| Gilead | 180 | $1,545,145 |
| AbbVie | 36 | $442,579 |
| Intercept Pharmaceuticals, Inc. | 86 | $380,565 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $31,616 |
| Intercept Pharma Europe Ltd. | 10 | $26,184 |
| Eli Lilly | 7 | $25,991 |
| Alnylam Pharmaceuticals Inc. | 12 | $19,035 |
| Novartis | 5 | $15,766 |
| Mirum Pharmaceuticals, Inc. | 3 | $13,909 |
| Merck | 11 | $13,532 |
| Ipsen Pharma SAS | 3 | $7,268 |
| Ipsen Biopharmaceuticals, Inc | 6 | $6,367 |
| Eiger Biopharmaceuticals, Inc. | 3 | $2,914 |
| Siemens Medical Solutions USA, Inc. | 4 | $2,397 |
| Viiv Healthcare Company | 1 | $2,214 |
| Theratechnologies Inc. | 2 | $2,066 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $522 |
| Novo Nordisk | 2 | $167 |
| Dova Pharmaceuticals | 1 | $132 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $118 |
| Boston Scientific | 4 | $89 |
How this compares
$4,288,376 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Detroit
- Reena SalgiaDetroit$1.3M
- Kimberly BrownDetroit$1.1M
- Nirmal KaurDetroit$789K
- Dilip MoonkaDetroit$768K
- Milton MutchnickDetroit$260K
- Humberto Gonzalez GonzalezDetroit$189K
- Edward ClayDetroit$79K
- Sumit SinglaDetroit$76K
- Tobias ZuchelliDetroit$39K
- Deepak VenkatDetroit$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.